Avalo Therapeutics CMO Mittie Doyle disposes of 679 common shares worth $13,580
AVTX•Chief medical officer sells shares after option exercise
- Avalo Therapeutics Chief Medical Officer Doyle Mittie sold 679 shares on Aug. 10 at USD 20.
- The sale followed an option exercise for 679 shares at USD 8.04.
- Mittie ended the day with 51,776 shares of common stock.
